Cédric Menard

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

François Ghiringhelli, Cédric Menard, Pierre E. Puig et al. · Cancer Immunology Immunotherapy · 2006 · 1.2K citations · Full text

Medicine, T-regulatory Cell, Immunology +10

CD4<b>+</b>CD25<b>+</b> regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner

François Ghiringhelli, Cédric Menard, Magali Terme et al. · The Journal of Experimental Medicine · 2005 · 911 citations · Full text

A novel dendritic cell subset involved in tumor immunosurveillance

Nathalie Chaput, Cédric Menard, Lionel Apétoh et al. · Nature Medicine · 2006 · 395 citations

Tumor Immunology, Cancer Immunosurveillance, Immunology +7

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

Nicolas F. Delahaye, Sylvie Rusakiewicz, Isabelle Martins et al. · Nature Medicine · 2011 · 315 citations · Full text

Oncology, Gastrointestinal Oncology, Medicine +8

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects

Christophe Borg, Magali Terme, Cédric Menard et al. · Journal of Clinical Investigation · 2004 · 284 citations